CARDIOPROTECTIVE EFFECTIVENESS OF SODIUM-GLUCOSE COTRANSPORTER-2 INHIBITORS IN EARLY BREAST CANCER FOLLOWING ANTHRACYCLINE- OR TRASTUZUMAB-BASED CHEMOTHERAPY

被引：0
|
作者：
Liu, Y. S. [1 ]
Barner, J. C. [1 ]
Lawson, K. [1 ]
Liu, Y. [1 ]
Park, C. [1 ]
机构：
[1] Univ Texas Austin, Austin, TX USA
来源：
VALUE IN HEALTH | 2024年 / 27卷 / 06期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
P20
引用
收藏
页码：S5 / S5
页数：1
相关论文
共 50 条
  • [21] Sodium-glucose cotransporter-2 inhibitors: an overview and perioperative implications
    Bardia, Amit
    Wai, Mabel
    Fontes, Manuel L.
    CURRENT OPINION IN ANESTHESIOLOGY, 2019, 32 (01) : 80 - 85
  • [22] The pleiotropic cardiovascular effects of sodium-glucose cotransporter-2 inhibitors
    Tanna, Monique S.
    Goldberg, Lee R.
    CURRENT OPINION IN CARDIOLOGY, 2021, 36 (06) : 764 - 768
  • [23] Renal effectiveness and safety of the sodium-glucose cotransporter-2 inhibitors: a population-based cohort study
    Alkabbani, Wajd
    Zongo, Arsene
    Minhas-Sandhu, Jasjeet K.
    Eurich, Dean T.
    Shah, Baiju R.
    Alsabbagh, Mhd Wasem
    Gamble, John-Michael
    BMJ OPEN DIABETES RESEARCH & CARE, 2021, 9 (02)
  • [24] Obesity as a modifier of the cardiovascular effectiveness of sodium-glucose cotransporter-2 inhibitors in type 2 diabetes
    Suissa, Karine
    Schneeweiss, Sebastian
    Douros, Antonios
    Yin, Hui
    Patorno, Elisabetta
    Azoulay, Laurent
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2022, 192
  • [25] Rationale for the Early Use of Sodium-Glucose Cotransporter-2 Inhibitors in Patients with Type 2 Diabetes
    Handelsman, Yehuda
    ADVANCES IN THERAPY, 2019, 36 (10) : 2567 - 2586
  • [26] Sodium-glucose cotransporter 2 inhibitors: A drug with antidiabetic and cardioprotective properties
    Li, Hung-Yuan
    JOURNAL OF DIABETES INVESTIGATION, 2021, 12 (03) : 310 - 312
  • [27] Rationale for the Early Use of Sodium-Glucose Cotransporter-2 Inhibitors in Patients with Type 2 Diabetes
    Yehuda Handelsman
    Advances in Therapy, 2019, 36 : 2567 - 2586
  • [28] Cost-effectiveness of sodium-glucose cotransporter-2 inhibitors in the treatment of diabetic nephropathy in Japan
    Maruyama-Sakurai, Keiko
    Tachimori, Hisateru
    Saito, Eiko
    Kohsaka, Shun
    Segawa, Yasumasa
    Miyata, Hiroaki
    Igarashi, Ataru
    DIABETES OBESITY & METABOLISM, 2024, 26 (12): : 5546 - 5555
  • [29] Impact of sodium-glucose cotransporter-2 inhibitors on heart failure and mortality in patients with cancer
    Chiang, Cho-Han
    Chiang, Cho-Hung
    Chiang, Cho-Hsien
    Ma, Kevin Sheng-Kai
    Peng, Chun-Yu
    Hsia, Yuan Ping
    Horng, Chuan-Sheng
    Chen, Cheng-Ying
    Chang, Yu-Cheng
    See, Xin Ya
    Chen, Yuan-Jen
    Wang, Shih-Syuan
    Suero-Abreu, Giselle A.
    Peterson, L. R.
    Thavendiranathan, Paaladinesh
    Armand, Philippe
    Peng, Cheng-Ming
    Shiah, Her-Shyong
    Neilan, Tomas G.
    HEART, 2023, 109 (06) : 470 - 477
  • [30] Potential Utility of Sodium-Glucose Cotransporter-2 Inhibitors in Treating Myocarditis
    Kim, Michael H.
    Suri, Yash
    Rajendran, Iniya
    Pineda, J. R. Exequiel T.
    AMERICAN JOURNAL OF MEDICINE, 2024, 137 (02): : e33 - e34
12345